Correlation of 124 I PET dosimetry with clinical response of 131 I therapy for metastatic differentiated thyroid cancer.
Institution: MedStar Health Research Institute | MedStar Washington Hospital CenterDepartment: Medicine/Nuclear MedicineForm of publication: ConferenceYear: 2013Conference information: Paper presented at: Society of Nuclear Medicine & Molecular Imaging., Vancouver, BC, 2013/06/08/ | Fiscal year: FY20133Local accession number: 2013_16Date added to catalog: 2014-04-14| Item type | Current library | Collection | Call number | Status | Date due | Barcode |
|---|---|---|---|---|---|---|
| Conference | MedStar Authors Catalog | Conference | Available |